Carl Anthony Evans - Net Worth and Insider Trading
Carl Anthony Evans Net Worth
The estimated net worth of Carl Anthony Evans is at least $102 dollars as of 2024-09-20. Carl Anthony Evans is the Director of CNS Pharmaceuticals Inc and owns about 669 shares of CNS Pharmaceuticals Inc (CNSP) stock worth over $102. Details can be seen in Carl Anthony Evans's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Anthony Evans has not made any transactions after 2024-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carl Anthony Evans
Carl Anthony Evans Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl Anthony Evans owns 1 companies in total, including CNS Pharmaceuticals Inc (CNSP) .
Click here to see the complete history of Carl Anthony Evans’s form 4 insider trades.
Insider Ownership Summary of Carl Anthony Evans
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNSP | CNS Pharmaceuticals Inc | 2024-02-01 | director |
Carl Anthony Evans Latest Holdings Summary
Carl Anthony Evans currently owns a total of 1 stock. Carl Anthony Evans owns 669 shares of CNS Pharmaceuticals Inc (CNSP) as of February 1, 2024, with a value of $102.
Latest Holdings of Carl Anthony Evans
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNSP | CNS Pharmaceuticals Inc | 2024-02-01 | 669 | 0.15 | 102 |
Holding Weightings of Carl Anthony Evans
Carl Anthony Evans Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl Anthony Evans has made a total of 1 transactions in CNS Pharmaceuticals Inc (CNSP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CNS Pharmaceuticals Inc is the acquisition of 667 shares on February 1, 2024, which cost Carl Anthony Evans around $10,000.
Insider Trading History of Carl Anthony Evans
- 1
Carl Anthony Evans Trading Performance
GuruFocus tracks the stock performance after each of Carl Anthony Evans's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl Anthony Evans is -13.66%. GuruFocus also compares Carl Anthony Evans's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl Anthony Evans within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carl Anthony Evans's insider trading performs compared to the benchmark.
Performance of Carl Anthony Evans
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.77 |  | | | | |
| Relative Return to S&P 500(%) | 18.06 | | | | | |
Carl Anthony Evans Ownership Network
Carl Anthony Evans Owned Company Details
What does CNS Pharmaceuticals Inc do?
Who are the key executives at CNS Pharmaceuticals Inc?
Carl Anthony Evans is the director of CNS Pharmaceuticals Inc. Other key executives at CNS Pharmaceuticals Inc include Chief Financial Officer Christopher Downs , director & Chief Executive Officer John M Climaco , and 10 percent owner Waldemar Priebe .
CNS Pharmaceuticals Inc (CNSP) Insider Trades Summary
Over the past 18 months, Carl Anthony Evans made 1 insider transaction in CNS Pharmaceuticals Inc (CNSP) with a net purchase of 33,333. Other recent insider transactions involving CNS Pharmaceuticals Inc (CNSP) include a net purchase of 184,416 shares made by John M Climaco , a net purchase of 96,766 shares made by Christopher Downs , and a net purchase of 43,006 shares made by Jerzy Gumulka .
In summary, during the past 3 months, insiders sold 0 shares of CNS Pharmaceuticals Inc (CNSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,886 shares of CNS Pharmaceuticals Inc (CNSP) were sold and 7,150 shares were bought by its insiders, resulting in a net purchase of 5,264 shares.
CNS Pharmaceuticals Inc (CNSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CNS Pharmaceuticals Inc Insider Transactions
Carl Anthony Evans Mailing Address
Above is the net worth, insider trading, and ownership report for Carl Anthony Evans. You might contact Carl Anthony Evans via mailing address: C/o Cns Pharmaceuticals, Inc., 2100 West Loop South Ste 900, Houston Tx 77027.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
